TL Genomics

Japan
Koganei, Tokyo, Japan, 184-8588

Company profile

TL Genomics company profile

TL Genomics is a developer of a prenatal diagnosis technology created to isolate fetal nucleated red blood cells in maternal blood.The company isolates fetal cells in maternal blood using a uniquely developed technology and examines the genome of the fetal cells, enabling noninvasive and definitive diagnosis of fetal chromosomal disease early in pregnancy.

Business identity

Contact email
[email protected]
Phone number
+81 0466-47-8655
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01

Headquarters

Postal code
184-8588
Country code
JP
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$3.8M
Last funding
Series B / $3M / 2018-05-07
Last equity funding
Series B / $3M
Investors
4
Lead investors
1
Founders
1

Founders and investors

Founders

Tomohiro Kubo

Lead investors

Nissay Capital

Investors

DBJ CapitalNEDONissay CapitalSMBC Venture Capital